CXT

Crane NXT, Co.

51
Fundamentals56/ 100
Valuation29/ 100
Upside potential44/ 100
Risk potential25/ 100

CXT's fundamentals are mixed, but it looks expensive: trading at 26x earnings, above its usual 19x. Analysts expect earnings growth.

EOSE

Eos Energy Enterprises, Inc.

There isn't enough reported data to score EOSE yet.

CXT Fundamentals

MetricStatus
Healthy
Stable
Strong
Under pressure

CXT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.

EOSE Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

CXT PE Valuation

CHEAPFAIREXPENSIVE58x116x174x232x
CHEAPFAIREXPENSIVE58x116x174x232x
LevelPEPriceVs current
Forward12x$56.99โ€”
Cheap15x$32.96-42%
Fair19x$41.21-28%
Current26x$56.99โ€”
Expensive27x$60.07+5.4%

Historical ranges are pointers, not guarantees.

CXT's PE is in its expensive range at 26x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its cheap range.

EOSE PE Valuation

EOSE has no meaningful PE right now: it lost money over the past year.

CXT Forward outlook

MetricOutlook
Strongly improving
Growth
Growth
Weakening
Limited
High

Analysts expect earnings and revenue growth for CXT, but weaker profitability.

EOSE Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
--
Limited
Low

Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

CXT Risk to reward

ScenarioChangePrice
Upside+20%$68.12
Downside-25%$42.77

Calculated from the latest close: $56.99 on Nov 12.

There is not enough scenario data to compare CXT and EOSE's risk to reward.

EOSE Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.81 on Nov 12.

There is not enough scenario data to compare CXT and EOSE's risk to reward.

CXT Earnings Per Share

Q1 2024: $3.17Q2 2024: $3.14Q3 2024: $3.05Q4 2024: $3.19Q1 2025: $2.91Q2 2025: $2.62Q3 2025: $2.68Q4 2025: $2.50Q1 2026: $2.23Q2 2026: $2.41Q3 2026: $2.20Forward: $4.58
Q1 2024: $3.17Q2 2024: $3.14Q3 2024: $3.05Q4 2024: $3.19Q1 2025: $2.91Q2 2025: $2.62Q3 2025: $2.68Q4 2025: $2.50Q1 2026: $2.23Q2 2026: $2.41Q3 2026: $2.20Forward: $4.58
QuarterTTM EPSYoY
Forward$4.58+108%
Q3 2026$2.20-18%
Q2 2026$2.41-8%
Q1 2026$2.23-23%
Q4 2025$2.50-22%
Q3 2025$2.68-12%
Q2 2025$2.62-17%
Q1 2025$2.91-8.2%
Q4 2022$2.43-4.7%

CXT has the stronger earnings trend. Trailing diluted EPS is down 18% for CXT versus EOSE down 224%.

EOSE Earnings Per Share

Q4 2024: $-4.55
Q4 2024: $-4.55
QuarterTTM EPSYoY
Q3 2023-$2.69+$0.85
Q2 2023-$3.76-$1.00
Q1 2023-$3.65-$0.86
Q4 2022-$3.68-$1.32
Q3 2022-$3.54+$5.19

EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.

CXT Quarterly Revenue

Q4 2023: $357MQ1 2024: $314MQ2 2024: $371MQ3 2024: $404MQ4 2024: $399MQ1 2025: $330MQ2 2025: $404MQ3 2025: $445MQ4 2025: $477MQ1 2026: $388MQ2 2026: $493MQ3 2026: $497M
Q4 2023: $357MQ1 2024: $314MQ2 2024: $371MQ3 2024: $404MQ4 2024: $399MQ1 2025: $330MQ2 2025: $404MQ3 2025: $445MQ4 2025: $477MQ1 2026: $388MQ2 2026: $493MQ3 2026: $497M
QuarterRevenueYoY
Q3 2026$497.1M+12%
Q2 2026$493.2M+22%
Q1 2026$387.7M+17%
Q4 2025$476.9M+19%
Q3 2025$445.1M+10%
Q2 2025$404.4M+9.1%
Q1 2025$330.3M+5.3%
Q4 2024$399.1M+12%

CXT's revenue has grown year over year for 10 quarters in a row: $497M last quarter, up 12% from the same quarter a year ago.

EOSE Quarterly Revenue

Q4 2023: $7MQ1 2024: $7MQ2 2024: $898,000Q3 2024: $854,000Q4 2024: $7MQ1 2025: $10MQ2 2025: $15MQ3 2025: $31MQ4 2025: $58MQ1 2026: $57MQ2 2026: $69MQ3 2026: $83M
Q4 2023: $7MQ1 2024: $7MQ2 2024: $898,000Q3 2024: $854,000Q4 2024: $7MQ1 2025: $10MQ2 2025: $15MQ3 2025: $31MQ4 2025: $58MQ1 2026: $57MQ2 2026: $69MQ3 2026: $83M
QuarterRevenueYoY
Q3 2026$82.7M+171%
Q2 2026$68.8M+351%
Q1 2026$57M+445%
Q4 2025$58M+700%
Q3 2025$30.5M+3473%
Q2 2025$15.2M+1597%
Q1 2025$10.5M+58%
Q4 2024$7.3M+9.7%

EOSE has the edge over CXT on sales, with stronger typical year-over-year growth.

CXT Free Cash Flow

Q4 2023: $64MQ1 2024: โˆ’$3MQ2 2024: $48MQ3 2024: $54MQ4 2024: $70MQ1 2025: โˆ’$32MQ2 2025: $56MQ3 2025: $79MQ4 2025: $96MQ1 2026: โˆ’$24MQ2 2026: $73MQ3 2026: $90M
Q4 2023: $64MQ1 2024: โˆ’$3MQ2 2024: $48MQ3 2024: $54MQ4 2024: $70MQ1 2025: โˆ’$32MQ2 2025: $56MQ3 2025: $79MQ4 2025: $96MQ1 2026: โˆ’$24MQ2 2026: $73MQ3 2026: $90M
QuarterFree cash flowYoY
Q3 2026$90.2M+15%
Q2 2026$73.4M+32%
Q1 2026-$24.1M+$8.1M
Q4 2025$96M+37%
Q3 2025$78.7M+47%
Q2 2025$55.8M+16%
Q1 2025-$32.2M-$29.2M
Q4 2024$70.3M+11%

CXT has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.

EOSE Free Cash Flow

Q4 2023: โˆ’$46MQ1 2024: โˆ’$45MQ2 2024: โˆ’$33MQ3 2024: โˆ’$54MQ4 2024: โˆ’$56MQ1 2025: โˆ’$34MQ2 2025: โˆ’$73MQ3 2025: โˆ’$83MQ4 2025: โˆ’$75MQ1 2026: โˆ’$155MQ2 2026: โˆ’$107MQ3 2026: โˆ’$105M
Q4 2023: โˆ’$46MQ1 2024: โˆ’$45MQ2 2024: โˆ’$33MQ3 2024: โˆ’$54MQ4 2024: โˆ’$56MQ1 2025: โˆ’$34MQ2 2025: โˆ’$73MQ3 2025: โˆ’$83MQ4 2025: โˆ’$75MQ1 2026: โˆ’$155MQ2 2026: โˆ’$107MQ3 2026: โˆ’$105M
QuarterFree cash flowYoY
Q3 2026-$105.1M-$22.4M
Q2 2026-$107.4M-$34.3M
Q1 2026-$154.8M-$121M
Q4 2025-$75.2M-$19.5M
Q3 2025-$82.7M-$28.5M
Q2 2025-$73.2M-$40.6M
Q1 2025-$33.8M+$10.7M
Q4 2024-$55.8M-$10.2M

EOSE has burned cash in almost every quarter: โˆ’$443M over the past year, against โˆ’$246M the year before.

CXT Total Shares

Q4 2023: 58MQ1 2024: 58MQ2 2024: 58MQ3 2024: 58MQ4 2024: 58MQ1 2025: 58MQ2 2025: 58MQ3 2025: 58MQ4 2025: 58MQ1 2026: 58MQ2 2026: 58MQ3 2026: 58M
Q4 2023: 58MQ1 2024: 58MQ2 2024: 58MQ3 2024: 58MQ4 2024: 58MQ1 2025: 58MQ2 2025: 58MQ3 2025: 58MQ4 2025: 58MQ1 2026: 58MQ2 2026: 58MQ3 2026: 58M
PeriodChange %Net change
Quarterly+0.2%+100K shares
1 year+0.2%+100K shares
3 years+1%+600K shares
5 years-66%-113M shares
Available history-67%-116M shares

CXT has the edge over EOSE on shareholder dilution, with a more favorable share count trend.

EOSE Total Shares

Q1 2024: 201MQ2 2024: 211MQ3 2024: 217MQ4 2024: 212MQ2 2025: 238MQ3 2025: 272MQ2 2026: 340MQ3 2026: 553M
Q1 2024: 201MQ2 2024: 211MQ3 2024: 217MQ4 2024: 212MQ2 2025: 238MQ3 2025: 272MQ2 2026: 340MQ3 2026: 553M
PeriodChange %Net change
Quarterly+63%+213M shares
1 year+161%+341M shares
3 years+888%+497M shares

EOSE has 553M diluted shares, up 161% from a year ago.

CXT Net Leverage

Q4 2023: 0.9xQ1 2024: 1.3xQ2 2024: 1.9xQ3 2024: 1.8xQ4 2024: 1.6xQ1 2025: 1.9xQ2 2025: 3.0xQ3 2025: 2.7xQ4 2025: 2.6xQ1 2026: 3.7xQ2 2026: 3.2xQ3 2026: 3.0x
Q4 2023: 0.9xQ1 2024: 1.3xQ2 2024: 1.9xQ3 2024: 1.8xQ4 2024: 1.6xQ1 2025: 1.9xQ2 2025: 3.0xQ3 2025: 2.7xQ4 2025: 2.6xQ1 2026: 3.7xQ2 2026: 3.2xQ3 2026: 3.0x
QuarterNet LeverageStatus
Q3 20263.0xElevated
Q2 20263.2xElevated
Q1 20263.7xElevated
Q4 20252.6xModerate
Q3 20252.7xModerate
Q2 20253.0xModerate
Q1 20251.9xHealthy
Q4 20241.6xHealthy

CXT's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.6 years a year ago.

EOSE Net Leverage

EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CXT Weekly Momentum

MetricValueStatus
RSI60.5Neutral
Stochastic73.0Neutral

CXT's weekly RSI is 61 (neutral) and its Stochastic is 73 (neutral).

EOSE Weekly Momentum

MetricValueStatus
RSI32.5Neutral
Stochastic7.4Oversold

EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

CXT PE vs Industrials Sector

MetricCXTSector medianRelative
PE26x24x7.8% above
PE %825824 pts above

CXT is trading at 26x earnings, in line with the Industrials sector's median of 24x.

EOSE PE vs Industrials Sector

EOSE has no meaningful PE right now: it lost money over the past year.

CXT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$54.05.6% above
20 week MA$52.29.2% above
50 week MA$48.817% above
100 week MA$53.17.3% above
200 week MA$54.15.4% above

CXT has the edge over EOSE on trend strength, trading above more of its moving averages.

EOSE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.2419% below
20 week MA$3.2845% below
50 week MA$7.0174% below
100 week MA$7.1075% below
200 week MA$4.5360% below

EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.

CXT Yearly ROI

YearStart priceEnd priceROI
2020$30.0$26.7-11%
2021$26.7$34.6+30%
2022$34.6$34.6-0.2%
2023$34.6$56.9+65%
2024$56.9$58.0+2%
2025$58.0$48.4-17%
2026 YTD$48.4$57.0+18%

CXT has the edge over EOSE on returns for 2026, with the stronger performance.

EOSE Yearly ROI

YearStart priceEnd priceROI
2020$9.72$19.2+98%
2021$19.2$8.57-55%
2022$8.57$1.08-87%
2023$1.08$1.09+0.9%
2024$1.09$5.17+374%
2025$5.17$11.9+129%
2026 YTD$11.9$1.81-85%

EOSE's yearly returns have swung widely, from +374% in 2024 to โˆ’87% in 2022. It's down 85% so far in 2026.

Give your agent the market.

Get API key